Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Simcere Pharmaceutical Group Passes This Key Test
Motley Fool
Monday, May 27, 2013 - 10:05am
tags:
Simcere
Gilead Sciences' Move Into Cancer Drugs
Seeking Alpha
Monday, May 27, 2013 - 9:50am
tags:
Gilead, Pharmacyclics, blood cancer, leukemia
China Biotech In Review: Hisun-Pfizer, Merck-Simcere JVs Come Into Focus
Seeking Alpha
Sunday, May 26, 2013 - 11:23am
tags:
Hisun, Pfizer, Merck, Simcere, 3SBio, JNJ, GSK, Curative Medical, ALung
New Pancreatic Cancer Drug an FDA Priority
Motley Fool
Sunday, May 26, 2013 - 11:20am
tags:
pancreatic cancer, Celgene, Abraxane
Hikma Has Up to $600 Million for Acquisitions, Darwazah Says
Bloomberg
Sunday, May 26, 2013 - 11:19am
tags:
Hikma
Sinovac Biotech Earnings: What Investors Should Watch
Wall Street Cheat Street
Sunday, May 26, 2013 - 11:18am
tags:
Sinovac Biotech
This Week in Biotech
Motley Fool
Sunday, May 26, 2013 - 11:18am
tags:
AcelRx, Peregrine Pharmaceuticals, Merck, XenoPort, Aveo Pharmaceuticals, Astellas
Big Pharma Learned The Wrong Marketing Lesson
Forbes
Saturday, May 25, 2013 - 12:41pm
tags:
Ista Pharmaceuticals To Pay $33.5 Million To Settle Claims Company Paid Doctors To Push Drug
Huffington Post
Saturday, May 25, 2013 - 12:40pm
tags:
ISTA Pharmaceuticals, lawsuits
5 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, May 25, 2013 - 12:38pm
tags:
Alimera, JNJ, Bristol-Myers Squibb, Watson Pharmaceuticals, Repros Therapeutics
1 Reason to Expect Big Things from West Pharmaceutical Services
Daily Finance
Saturday, May 25, 2013 - 12:37pm
tags:
West Pharmaceutical
Valeant Reportedly Nearing Deal To Buy Bausch & Lomb For $9 Bln
NASDAQ
Saturday, May 25, 2013 - 12:35pm
tags:
Valeant Pharmaceuticals, Bausch & Lomb, M&A
Evoke Pharma has filed for a $24M IPO. The company is a specialty pharmaceutical developer...
Seeking Alpha
Saturday, May 25, 2013 - 12:33pm
tags:
Evoke Pharma, IPOs
3 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, May 25, 2013 - 12:32pm
tags:
Vivus, Cempra, Corcept Therapeutics
Obamacare Will Bring Drug Industry $35 Billion In Profits Comment Now Follow Comments
Forbes
Saturday, May 25, 2013 - 12:27pm
tags:
Obamacare, health care reform
Pfizer Will Reward Shareholders With Zoetis Spin-Off
Seeking Alpha
Saturday, May 25, 2013 - 12:26pm
tags:
Pfizer, Zoetis
Siga Ruled Liable for Breaking PharmAthene Drug Contract
Bloomberg
Saturday, May 25, 2013 - 12:25pm
tags:
SIGA technologies, PharmAthene, lawsuits
Eli Lilly And Company (LLY): Today's Featured Drugs Laggard
The Street
Saturday, May 25, 2013 - 12:24pm
tags:
Eli Lilly
Actavis says court blocks generic Pulmicort
Yahoo/AP
Saturday, May 25, 2013 - 12:23pm
tags:
Actavis, generics, Pulmicort
Bristol-Myers Squibb (BMY) Shares Cross 3% Yield Mark
Forbes
Saturday, May 25, 2013 - 12:15pm
tags:
Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.